Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
Annaly Capital Management
NLY
$17.6B
| $24.9M | ﹤0.01% |
1,241,525
+9,625
| +0.8% | +$193K |
|
1802
PUT
SAP
SAP
$240B
| $24.9M | ﹤0.01% |
108,600
+4,800
| +5% | +$1.02M |
|
|
NUVL
1803
DELISTED
Nuvalent
NUVL
| $24.8M | ﹤0.01% |
242,558
+236,774
| +4,094% | +$19.6M |
|
1804
PUT
Edison International
EIX
$27.5B
| $24.8M | ﹤0.01% |
284,200
+160,600
| +130% | +$13M |
|
1805
Cogent Communications
CCOI
$579M
| $24.7M | ﹤0.01% |
325,957
+215,963
| +196% | +$14.9M |
|
1806
SiteOne Landscape Supply
SITE
$4.3B
| $24.7M | ﹤0.01% |
163,596
-28,897
| -15% | -$3.96M |
|
1807
Resideo Technologies
REZI
$3.1B
| $24.7M | ﹤0.01% |
1,225,195
+686,429
| +127% | +$13.6M |
|
1808
Lumen
LUMN
$6.93B
| $24.7M | ﹤0.01% |
3,472,842
+3,456,095
| +20,637% | +$14.8M |
|
1809
ServiceNow
NOW
$128B
| $24.6M | ﹤0.01% |
137,670
+75,300
| +121% | +$12.4M |
|
1810
Lexeo Therapeutics
LXEO
$397M
| $24.6M | ﹤0.01% |
2,723,363
+164,752
| +6% | +$1.96M |
|
|
TMHC
1811
DELISTED
Taylor Morrison
TMHC
| $24.6M | ﹤0.01% |
350,268
+134,621
| +62% | +$8.62M |
|
1812
Insmed
INSM
$27B
| $24.6M | ﹤0.01% |
336,562
-463,184
| -58% | -$34.2M |
|
1813
PUT
California Resources
CRC
$4.73B
| $24.5M | ﹤0.01% |
467,500
-21,700
| -4% | -$1.1M |
|
1814
PUT
Emcor
EME
$36.9B
| $24.5M | ﹤0.01% |
56,900
-600
| -1% | -$226K |
|
|
PPLI
1815
People Inc
PPLI
$3.01B
| $24.4M | ﹤0.01% |
553,396
+228,640
| +70% | +$9.52M |
|
1816
iShares Core S&P Small-Cap ETF
IJR
$114B
| $24.4M | ﹤0.01% |
208,869
+82,368
| +65% | +$9.31M |
|
1817
PUT
Sunrun
RUN
$2.45B
| $24.4M | ﹤0.01% |
1,351,200
+54,800
| +4% | +$974K |
|
1818
CRISPR Therapeutics
CRSP
$5.18B
| $24.4M | ﹤0.01% |
518,547
+375,985
| +264% | +$19.1M |
|
1819
Diageo
DEO
$53.1B
| $24.3M | ﹤0.01% |
172,983
+88,069
| +104% | +$11.4M |
|
1820
CALL
Ally Financial
ALLY
$13.7B
| $24.3M | ﹤0.01% |
682,000
+64,800
| +10% | +$2.59M |
|
1821
Tyson Foods
TSN
$20.5B
| $24.2M | ﹤0.01% |
406,842
+326,535
| +407% | +$19.9M |
|
1822
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $24.2M | ﹤0.01% |
421,705
-453,086
| -52% | -$24.5M |
|
1823
PUT
Mobileye
MBLY
$7.58B
| $24.2M | ﹤0.01% |
1,766,900
+677,300
| +62% | +$11.9M |
|
1824
PUT
Academy Sports + Outdoors
ASO
$2.98B
| $24.2M | ﹤0.01% |
414,200
-153,100
| -27% | -$8.36M |
|
1825
CALL
Takeda Pharmaceutical
TAK
$56.3B
| $24.1M | ﹤0.01% |
1,695,400
+831,200
| +96% | +$11.8M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,611 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,611 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.